Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The leukemias

H D Preisler1

  • 1Division of Hematology/Oncology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.

Disease-A-Month : DM
|October 1, 1994
PubMed
Summary

Leukemia treatment has advanced, with acute forms now curable via chemotherapy and bone marrow transplants. Recent progress offers potential cures for chronic leukemia, shifting treatment goals from management to remission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of the farnesyl transferase inhibitor FTI L-778,123 on normal, myelodysplastic, and myeloid leukemia bone marrow progenitor proliferation in vitro.

Leukemia & lymphoma·2003
Same author

Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx.

Auris, nasus, larynx·2002
Same author

Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.

Cancer treatment and research·2001
Same author

Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.

Cancer treatment and research·2001
Same author

P15INK4B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients.

Leukemia·2001
Same author

Alterations in IRF1/IRF2 expression in acute myelogenous leukemia.

American journal of hematology·2001

Area of Science:

  • Hematology
  • Oncology

Background:

  • Leukemias are classified as acute or chronic, with myelocytic and lymphocytic subtypes.
  • Acute leukemias typically present with a faster clinical course than chronic leukemias.
  • Historically, acute leukemias were curable with chemotherapy, while chronic leukemias were not.

Purpose of the Study:

  • To review the current treatment landscape for acute and chronic leukemias.
  • To highlight recent advances in chronic leukemia treatment.
  • To discuss the role of chemotherapy and bone marrow transplantation in leukemia management.

Main Methods:

  • Review of existing literature on leukemia classification and treatment.
  • Analysis of treatment outcomes for acute and chronic leukemia subtypes.
  • Discussion of emerging therapeutic strategies.

Main Results:

  • Acute leukemias are primarily treated with intensive chemotherapy, often leading to cure but with significant side effects.
  • Bone marrow transplantation is increasingly utilized for younger patients with acute leukemias.
  • Recent therapeutic advances suggest the possibility of curing some chronic leukemia cases, moving beyond the traditional goal of prolonged remission.

Conclusions:

  • Chemotherapy and bone marrow transplantation remain cornerstones for acute leukemia treatment.
  • Emerging therapies hold promise for achieving cures in chronic leukemias.
  • The treatment paradigm for leukemia is evolving towards curative strategies for both acute and chronic forms.

Related Experiment Videos